CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Buy
53
GEL Quote, Financials, Valuation and Earnings
Last price:
$14.38
Seasonality move
:
4.89%
Day range:
$13.48 - $13.98
52-week range:
$9.86 - $16.44
Dividend yield:
4.62%
P/E ratio:
34.62x
P/S ratio:
0.58x
P/B ratio:
1.55x
Volume:
492.9K
Avg. volume:
433.5K
1-year change:
8.38%
Market cap:
$1.7B
Revenue:
$3B
EPS (TTM):
-$1.24
Genesis Energy LP Number of Institutional Trades
Genesis Energy LP Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$2.9B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$1.1B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Genesis Energy LP Institutional Ownership
-
What Percentage Of GEL Is Owned by Institutions?
-- of GEL is owned by institutions.
-
How Many Institutions Own GEL Shares?
Genesis Energy LP stock is owned by 152 institutional shareholders at this time.
-
Have Institutions Been Buying GEL Stock?
Yes, institutions have bought 116.4M shares of GEL in the last quarter.
-
Have Institutions Been Selling GEL Stock?
Yes, institutions have sold 40.6M shares of GEL over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is down 0% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 21.54% over the past day.
